Deliver Your News to the World

Pfizer Names Amal Naj Vice President, Investor Development and Strategy


NEW YORK, January 24 -- Pfizer Inc said today it has named Amal Naj Vice President, Investor Development and Strategy. He succeeds Jim Gardner, who will retire in April after 29 years of distinguished service to Pfizer.

In his new position, Naj will work closely with Pfizer’s senior management in representing Pfizer’s business to investors and analysts in the U.S. and overseas. He will report to David Shedlarz, Pfizer’s vice chairman.

“Amal brings considerable operational and communication experience and joins us at a critical time for Pfizer as we take action on a number of fronts to leverage our competitive strengths and to build the investment value of our company,” said Shedlarz. “We will continue to be active in communicating our performance, strategy and future opportunities to our shareholders and the investment community.”

Naj joined Pfizer in 1996 and has served as Country Manager, Thailand and Indochina since 2000. During this time, he led a six-fold increase in Pfizer’s business in the region. He also was instrumental in advancing Pfizer’s philanthropy and community support activities including the response to last year’s Asian tsunami as well as programs focused on higher education and supporting people living with HIV/AIDS. His early career at Pfizer included positions of increasing responsibility in corporate affairs and business development, planning and strategy.

Prior to joining Pfizer, Naj had a 17 year career as a journalist with The Wall Street Journal, where he covered a wide range of industries from Pittsburgh, Detroit and New York. Naj received an undergraduate degree in science from the University of Bombay and later pursued graduate studies in economics and philosophy at Queen’s University in Northern Ireland.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.